Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study

Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study

Sorafenib, an oral multikinase inhibitor, is approved for advanced hepatocellular carcinoma (HCC) treatment. However, its therapeutic effect in advanced HCC patients with extrahepatic metastasis remains uncertain. This study aimed to prospectively assess the efficacy, safety, and survival risk facto...

Full description

Bibliographic Details
Main Authors: Nakano, Masahito, Tanaka, Masatoshi, Kuromatsu, Ryoko, Nagamatsu, Hiroaki, Tajiri, Nobuyoshi, Satani, Manabu, Niizeki, Takashi, Aino, Hajime, Okamura, Shusuke, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Koga, Hironori, Torimura, Takuji
Format: Online
Language:English
Published: John Wiley and Sons Inc. 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123720/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123720/

Similar Items